I. Maremmani, A. Lazzeri, S. Canoniero, M. Aglietti, G.F. Placidi - Volume 5, Settembre 1999, n.3
Testo Immagini Bibliografia Summary Riassunto Indice
Abuso di sostanze e psicosi croniche
Substance abuse and chronic psychoses
1) American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders, 3d ed. Revised (DSM-III-R).
Washington DC: A.P.A. 1987.
2) American Psychiatric Association.
DSM-IV. Diagnostic and Statistical Manual of Mental Disorders.
4th ed. Washington: A.P.A. 1994.
3) Allebeck P.
Schizophrenia and cannabis: cause-effect relationship.
In: Nahas GG, Latour C, eds. Cannabis: physiopathology, epidemiology, detection.
Boca Raton, Florida: CRC Press 1993:113-117.
4) Allebeck P, Adamson C, Engstrom A.
Cannabis and schizophrenia: a longitudinal study of cases treated in Stockolm
Country.
Acta Psychiatrica Scandinavica 1993;88:21-24.
5) Altman H, Evenson RC.
Marijuana use and subsequent psychiatric symptoms: a replication.
Comprehensive Psychiatry 1973;14:415-420.
6) Ando K, Hironaka N, Yanagita T.
Psychotic manifestations in amphetamine abuse: experimental study on the
mechanism of psychotic recurrence.
Psychopharmacology Bullettin 1986;22:763-767.
7) Andreasson S, Allebeck P, Engstrom A, Rydberg U.
Cannabis and schizophrenia.
Lancet 1987;2:1483-1485.
8) Andreasson S, Allebeck P, Ryberg U.
Schizophrenia in users and nonusers of cannabis: a longitudinal study in
Stockholm Country.
Acta Psychiatrica Scandinavica 1989;79:505-510.
9) Arndt S, Tyrrel G, Flaum M, Andreasen NC.
Comorbidity of substance abuse and schizophrenia: the role of pre-morbid
adjustment.
Psychological Medicine 1992;22:379-388.
10) Bell DS.
Comparison of amphetamine psychosis and schizophrenia.
British Journal of Psychiatry 1965;3:701-706.
11) Benabud A.
Psychopathological aspects of the cannabis situation in Morocco: statistical
data for 1956.
Bulletin on Narcotics 1956;9:2-5.
12) Bernhardson G, Gunne LM.
Forty-six cases of psychosis in cannabis abusers.
International Journal of Addictions 1972;7:9-16.
13) Bowers MB.
Psychoses precipitated by psychotomimetics drugs.
Archives of General Psychiatry 1977;34:832-835.
14) Bowers MB, Swigar ME.
Vulnerability to psychosis associated with hallucinogen use.
Psyhiatric Research 1983;9:91-97.
15) Bowers MBJ.
The role of drugs in the production of schizophreniform psychoses and related
disorders.
Linptom MA, Di Mascio A, Killam KF Eds., Psychopharmacology: A generation
of Progress.
New York: Raven 1978:819-823.
16) Bowers MBJ, Iminowica R, Druss B, Mazure CH.
Autonomous psychosis following psychotogenic substance abuse.
Biological Psychiatry 1995;37:136-137.
17) Bowers MBJ, Mazure CM, Nelson JC, Jatlow PI.
Psychotogenic drug use and neuroleptic response.
Schizophrenia Bullettin 1990;16:81-85.
18) Breakey WR, Goodell H, Lorenz PC, McHugh PR.
Hallucinogenic drugs as precipitants of schizophrenia.
Psychological Medicine 1974;4:255-261.
19) Bromberg W.
Marijuana: a psychiatric study.
Journal of American Medical Association 1993;4:836-847.
20) Byrne A, Kirby B, Zibin T, Ensmingers S.
Psychiatric and neurological effects of chronic solvent abuse.
Canadian Journal of Psychiatry 1991;36:735-738.
21) Carney MWP, Bacelle L.
Psychosis after cannabis abuse (letter).
British Medical Journal 1984;288:1047.
22) Cassidy G, Ballard CG.
Psychiatric sequelae of MDMA and related drugs.
Irish Journal of Psychological Medicine 1994;11:132-133.
23) Caton CLM, Gralnick A, Bender S, Simon R.
Young chronic patients and substance abuse.
Hospital and Community Psychiatry 1989;40:1037-1040.
24) Charles-Nicolas AJ.
La psychose cronique due à l’abus des amphetamines existe-elle?
Nouvelle Presse Medicale 1976;5:2447-2450.
25) Chopra GS, Smith JW.
Psychotic reactions following cannabis use in East Indians.
Archives of General Psychiatry 1974;30:24-27.
26) Cleghorn JM, Kaplan RD, Szechtmann B, Szechtmann H, Brown GM, Franco
S.
Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive
function.
Journal of Clinical Psychiatry 1991;52:26-30.
27) Connell PH.
Amphetamine Psychosis.
In: Maudsley Monographs, n°5. New York: Oxford University Press 1958:15-36.
28) Cuffel BJ, Heithoff KA, Lawson W.
Correlates of patterns of substance abuse among patients with schizophrenia.
Hospital and Community Psychiatry 1993;44:247-251.
29) Davis BL.
The PCP epidemic: a critical review.
International Journal of Addictions 1982;17:1137-1155.
30) Fauman BJ, Fauman MA.
Phencyclidine psychosis occurring in the middle-aged man: report of a case
(letter).
Illinois Medical Journal 1978;154:325.
31) Gersten SP.
Long-term adverse effects of brief marijuana usage.
Journal of Clinical Psychiatry 1980;41:60-61.
32) Glass GS, Bowers MB.
Chronic psychosis associated with long-term psychotomimetic drug abuse.
Archives of General Psychiatry 1970;23:97-103.
33) Goldbloom D, Chouinard G.
Schizophreniform psychosis associated with chronic industrial toluene exposure:
case report.
Journal of Clinical Psychiatry 1985;46:350-351.
34) Grinspoon L, Bakalar JB.
Marijuana.
In: Lowinson JH, Ruiz P, Millman RB, eds. Substance Abuse: a Comprehensive
Textbook.
Baltimore: Williams and Wilkins 1992:236-246.
35) Harding T, Knight F.
Marijuana-modified mania.
Archives of General Psychiatry 1973;29:635-637.
36) Hatrick JA, Dewhurst K.
Delayed psychosis due to LSD.
Lancet 1970;2:742-744.
37) Hein D.
Special considerations for dually diagnosed schizophrenics and their families.
In: Solomon J, Zimberg S, Schollar E, eds. Dual Diagnosis.
New York: Plenum 1993:193-214.
38) Hermle L, Spitzer M, Borchardt D, Kovar KA, Gouzoulis M.
Psychological effects of MDE in normal subjects: are entactogens a new
class of psychoactive agents?
Neuropsychopharmacology 1993;8:171-176.
39) Horowitz HA.
The use of lithium in treatment of drug-induced psychotic reactions.
Diseases of the Nervous System 1975;36:159-163.
40) Imade AGT, Ebie JC.
A retrospective study of symptom patterns of cannabis-induced psychosis.
Acta Psychiatrica Scandinavica 1991;83:134-136.
41) Javitt DC.
Negative schizophrenic symptomatology and the PCP model of schizophrenia.
Hillside Journal of Clinical Psychiatry 1987;9:12-35.
42) Keenan E, Gervin M
Psychosis and recreational use of MDMA (ecstasy).
Irish Journal of Psychological Medicine 1993;10:162-163.
43) Keup W.
Psychotic symptoms due to cannabis abuse.
Diseases of the Nervous System 1970;31:119-126.
44) Knight F.
Role of cannabis in psychiatry disturbance.
Annals of the New York Academy of Science 1976;282:64-71.
45) Kolansky H, Moore WT.
Effects of marijuana on adolescents and young adults.
Journal of American Medical Association 1971;216:486-492.
46) Lazzeri AG.
Quadri psicotici dopo uso di sostanze. Caratteristiche clinico-anamnestiche.
Tesi di Specializzazione in Psichiatria.
Pisa 1996/97.
47) Linszen DH, Dingemans PM, Lenior ME.
Cannabis abuse and the course of recent-onset schizophrenia disorders.
Archives of General Psychiatry 1994;51:273-279.
48) Maremmani I, De Petris PG, Lamanna F, Tagliamonte A.
Disturbi Correlati a Sostanze. Allucinogeni.
In: Cassano GB, Pancheri P, Pavan L, Pazzagli A, Ravizza L, Rossi R, Smeraldi
E, Volterra V, eds. Trattato Italiano di Psichiatria. II ed. Milano:
Masson 1999:1392-1398.
49) Maremmani I, Di Furia L, Schifano F.
Disturbi Correlati a Sostanze. Amfetamino (simili) e designer drugs.
In: Cassano GB, Pancheri P, Pavan L, Pazzagli A, Ravizza L, Rossi R, Smeraldi
E, Volterra V, eds. Trattato Italiano di Psichiatria. II ed. Milano:
Masson 1999:1407-1410.
50) Maremmani I, Marini G, Tagliamonte A, Lenzi A.
Disturbi Correlati a Sostanze. Cannabinoidi.
In: Cassano GB, Pancheri P, Pavan L, Pazzagli A, Ravizza L, Rossi R, Smeraldi
E, Volterra V, eds. Trattato Italiano di Psichiatria. II ed. Milano:
Masson 1999:1385-1391.
51) Maremmani I, Meloni D, Gambarana C, Tagliamonte A.
Disturbi Correlati a Sostanze. Cocaina.
In: Cassano GB, Pancheri P, Pavan L, Pazzagli A, Ravizza L, Rossi R, Smeraldi
E, Volterra V, eds. Trattato Italiano di Psichiatria. II ed. Milano:
Masson 1999:1378-1384.
52) Martin BR.
Marijuana.
In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation
of progress.
New York: Raven Press 1995:1757-1765.
53) Mathers DC, Ghodse AH, Caan AW, Scott SA.
Cannabis use in a large sample of acute psychiatric admissions.
British Journal of Addiction 1991;86:779-784.
54) McGuire PK, Cope H, Fahy TA.
Diversity of psychopathology associated with use of 3,4-Mmethylendioxymethamphetamine
(ecstasy).
British Journal of Psychiatry 1994;165:391-395.
55) McLellan AT, Woody GE, O’Brien CP.
Development of psychiatric illness in drug abusers: Possible role of drug
preference.
New England Journal of Medicine 1979;301:1310-1314.
56) Muller DJ.
ECT in LSD psychosis: a report of three cases.
American Journal of Psychiatry 1971;128:351-352.
57) Murphy ABM.
The cannabis habit: a review of the recent cannabis literature.
Addiction 1966;13:3-7.
58) Nahas G.
Historical outlook of the psychopatology of cannabis.
In: Nahas G, ed. Cannabis: Physiopathology, Epidemiology, Detection.
Boca Raton FL: CRC Press 1993:105-112.
59) Nakatani Y, Yoshizawa J, Yamada H, Iwanami A, Sakaguchi M, Katoh N.
Methamphetamine psychosis in Japan: a survey.
British Journal of Addiction 1989;84:1548-1549.
60) Negrete JC.
Psychiatric effects of cannabis use.
In: Fehr K, Kalant H, eds. Papers for the ARF/WHO Scientific Meeting.
Toronto: ARF/WHO 1981:0.
61) Negrete JC.
Effects of cannabis on schizophrenia.
In: Nahas GG, Latour C, eds. Cannabis: Physiopathology, epidemiology, detection.
Boca Raton Florida: CRC Press 1993:105-112.
62) Nunez-Dominguez LA.
Psychosis because of ecstasy.
Addiciones 1994;6:301-307.
63) Oepen G, Levy M, Saemann R, Harrington A, Handren M, Pinnone L, Pollen
L, Ellison J, Boshes R.
A neuropsychological perspective on dual diagnosis.
Journal of Psychoactive Drugs 1993;25:129-133.
64) Overall JE, Gorham DR.
The Brief Psychiatric Rating Scale.
Psychological Reports 1962;10:799-812.
65) Palsson A, Thulin O, Tunving K.
Cannabis psychoses in South Sweden.
Acta Psychiatrica Scandinavica 1982;66:311-321.
66) Post R.
Cocaine Psychosis: a continuum model.
American Journal of Psychiatry 1975;132:225-230.
67) Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK.
Comorbidity of mental disorders with alchool and other drug abuse.
Journal of the American Medical Association 1990;19:2511-2518.
68) Ron MA.
Volatile Substance Abuse: A review of possible long-term neurological,
intellectual and psychiatric sequelae.
British Journal of Psychiatry 1986;148:235-246.
69) Rottanburg D, Robins AH, Oved B, Ben-Arie O, Teggin A, Elk R.
Cannabis-associated psychosis with hypomanic features.
Lancet 1982;18:1364-1366.
70) Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F.
Psychiatric diagnosis of treatment seeking cocaine abusers.
Archives of General Psychiatry 1991;48:43-51.
71) Satel SL, Edell WS.
Cocaine-induced paranoia and psychosis proneness.
American Journal of Psychiatry 1991;148:1708-1711.
72) Sato M.
A lasting vulnerability to psychosis in patients with previous methamphetamine
psychosis.
Annals of the New York Academy of Science 1986;472:160-170.
73) Sato M, Chen CC, Akiyama K, Otsuki S.
Acute exacerbation of paranoid psychotic state after long-term abstinence
in patients with previous methamphetamine psychosis.
Biological Psychiatry 1983;18:429-440.
74) Scher M, Neppe V.
Carbamazepine adjunct for nonresposive psychosis with prior hallucinogenic
abuse.
Journal of Nervous and Mental Disease 1991;177:755-757.
75) Schifano F.
Chronic atypical psychosis associated with MDMA (ecstasy) abuse (letter).
Lancet 1991;338:1335.
76) Schuckit MA.
The relationship between alcohol problems, substance abuse, and psychiatric
syndromes. DSM-IV sourcebook, vol.1. Washington, DC: American Psychiatric
Association 1994:15-36.
77) Series H, Boeles S
Psychiatric complications of "ecstasy" use.
Journal of Psychopharmacology 1994;8:60-61.
78) Sijuwola OA.
Comparative study of psychosis associated with cannabis.
West African Journal of Medicine 1986;5:271-276.
79) Spencer DJ.
Cannabis-induced psychosis.
International Journal of Addictions 1971;6:323-326.
80) Strassman RJ.
Adverse reactions to psychedelic drugs: a review of the literature.
Journal of Nervous and Mental Disease 1984;172:577-595.
81) Talbott JA, Teague JW.
Marijuana psychosis. Acute toxic psychosis associated with the use of cannabis
derivatives.
Journal of the American Medical Association 1969;210:299-302.
82) Tardiff K.
Assesment & management of violent patient.
Washington: American Psychiatric Press 1989.
83) Tennant FS, Groesbeck CJ.
Psychiatric effects of hashish.
Archives of General Psychiatry 1972;27:133-136.
84) Thacore VR.
Bhang psychosis.
British Journal of Psychiatry 1973;123:225-229.
85) Thacore VR, Shukla SRP.
Cannabis psychosis and paranoid schizophrenia.
Archives of General Psychiatry 1976;33:383-386.
86) Thornicroft G.
Cannabis and psychosis: is there epidemiological evidence for an association?
British Journal of Psychiatry 1990;157:25-33.
87) Tomiyama G.
Chronic schizophrenia-like states in methamphetamine psychosis.
Japanese Journal of Psychiatry and Neurology 1990;44:531-539.
88) Tsuang M, Simpson J, Kronfol Z.
Subtypes of drug abuse with psychosis.
Archives of General Psychiatry 1982;39:141-147.
89) Turner WM, Tsuang MT.
Impact of substance abuse on the course and outcome of schizophrenia.
Schizophrenia Bullettin 1990;16:87-95.
90) Utena H.
Behavioral aberrations in methamphetamine intoxicated animals and chemical
correlates in the brain.
In: Tokizanet T, Schade JP, eds. Progress in Brain Research, vol. 21B.
Amsterdam: Elsevier 1966:192-207.
91) Vardy M, Kay S.
LSD psychosis or LSD-induced schizophrenia?
Archives of General Psychiatry 1983;40:877-883.
92) Varma LP.
Cannabis psychosis.
Indian Journal of Psychiatry 1972;14:241-255.
93) Weller MP, Ang PC, Latimer-Sayer DI, Zachary L.
Drug abuse and mental illness (letter).
Lancet 1988;1:997.
94) Mania and depression: a classification of syndrome and disease.
Baltimore: Johns Hopkins University Press 1991.
95) Wright HH, Cole EA, Batey SR, Hanna K.
Phencyclidine-induced psychosis: eight-year follow-up of ten cases.
Southern Medical Journal 1988;81:565-567.
96) Yukitaki EA.
Amphetamine psychosis in Tokyo: its clinical features and social problems.
Folia Psychiatrica and Neurologica Japonica 1983;37:115-120.